Incyte Corp (NASDAQ:INCY)

101.66
Delayed Data
As of Apr 17
 -1.10 / -1.07%
Today’s Change
42.94
Today|||52-Week Range
103.74
+39.05%
Year-to-Date

Today’s Trading

Previous close102.76
Today’s open101.76
Day’s range101.01 - 102.74
Volume1,768,573
Average volume (3 months)1,196,688
Market cap$17.6B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+13.58%
Earnings growth (next 5 years)+209.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-1.77-1.86%
BMRNBiomarin Pharmaceuti...-0.75-0.61%
PCYCPharmacyclics Inc-0.57-0.22%
HSPHospira Inc-0.21-0.24%
Data as of 4:03pm ET, 04/17/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers